Stay updated on Pembrolizumab with Radium-223 in mCRPC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added a Locations section showing Massachusetts as an enrollment site, replacing the prior Massachusetts Locations entry with a unified Locations block.
    Difference
    0.4%
    Check dated 2025-12-24T12:00:34.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Added related topics links for Prostate cancer and MedlinePlus Genetics; no changes to the main study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-16T22:27:04.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page removed related topics Prostate cancer and MedlinePlus Genetics, with no changes to the core study content visible on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-09T20:02:12.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    Added related topics Prostate cancer and MedlinePlus Genetics and updated the page revision label from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-25T14:43:50.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Funding notice and related-topic links were removed from the page; the main study details and trial information remain unchanged.
    Difference
    0.5%
    Check dated 2025-11-18T07:30:22.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Added related topics links for Prostate cancer and MedlinePlus Genetics, affecting navigation but not study data or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-11T03:23:45.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Radium-223 in mCRPC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radium-223 in mCRPC Clinical Trial page.